FDA approves LINZESS for children ages 2-5 with functional constipation

May 27, 2026 10:00 AM

The U.S. Food and Drug Administration has approved the expanded use of LINZESS (linaclotide) for pediatric patients 2 years of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found